{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:50:43Z","timestamp":1781941843830,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470136 Y.R.C"],"award-info":[{"award-number":["82470136 Y.R.C"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170127"],"award-info":[{"award-number":["82170127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-2-003"],"award-info":[{"award-number":["2022-I2M-2-003"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507802"],"award-info":[{"award-number":["2023YFC2507802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtha.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:46:01Z","timestamp":1769701561000},"page":"1346-1358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bone marrow proteomic profiling reveals TMEM109 as a biomarker for relapse in thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-5364","authenticated-orcid":false,"given":"Qing","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mankai","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.01.003_bib1","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.003_bib3","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618825309","article-title":"Comparison of the long-term remission of rituximab and conventional treatment for acquired thrombotic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"25","author":"Owattanapanich","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.01.003_bib6","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.jtha.2025.06.002","article-title":"International Society on Thrombosis and Haemostasis. 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura","volume":"23","author":"Zheng","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.003_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib8","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib9","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/bloodadvances.2019031039","article-title":"Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura","volume":"3","author":"Sun","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.01.003_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.01.003_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ajh.25845","article-title":"Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: a multi-institutional study","volume":"95","author":"Schieppati","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib12","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2016-06-724161","article-title":"Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura","volume":"128","author":"Page","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.2008.07107.x","article-title":"Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse","volume":"141","author":"Jin","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative proteomics of the cancer cell line encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2026.01.003_bib15","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/bjh.19420","article-title":"Proteomics landscape and machine learning prediction of long-term response to splenectomy in primary immune thrombocytopenia","volume":"204","author":"Sun","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1301227","article-title":"Predicting the efficacy of glucocorticoids in pediatric primary immune thrombocytopenia using plasma proteomics","volume":"14","author":"Cao","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.01.003_bib17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/bjh.17720","article-title":"Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia","volume":"194","author":"Sun","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107875","article-title":"Adipocyte fatty acid transfer supports megakaryocyte maturation","volume":"32","author":"Valet","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtha.2026.01.003_bib19","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.003_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.003_bib21","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.2020009150","article-title":"Redefining outcomes in immune TTP: an international working group consensus report","volume":"137","author":"Cuker","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12967-022-03364-0","article-title":"Machine learning for the prediction of acute kidney injury in patients with sepsis","volume":"20","author":"Yue","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.jtha.2026.01.003_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1184700","article-title":"Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study","volume":"14","author":"Kong","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.01.003_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.2022019297","volume":"141","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib25","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1182\/blood-2016-03-703827","article-title":"Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura","volume":"127","author":"Page","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib26","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1182\/blood-2016-04-710475","article-title":"Adjuvant rituximab to prevent TTP relapse","volume":"127","author":"Cuker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/bjh.18127","article-title":"Mind and matter: the neurological complications of thrombotic thrombocytopenic purpura","volume":"197","author":"Shaw","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib28","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood-2013-04-496752","article-title":"Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura","volume":"122","author":"Deford","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/asheducation-2018.1.530","article-title":"Clinical and laboratory diagnosis of TTP: an integrated approach","volume":"2018","author":"Chiasakul","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2026.01.003_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/ijlh.13295","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13","volume":"42","author":"Mackie","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib31","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.003_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/1096-8652(200101)66:1<12::AID-AJH1001>3.0.CO;2-I","article-title":"Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome","volume":"66","author":"Mauro","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib34","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/ATVBAHA.110.207522","article-title":"Signaling during platelet adhesion and activation","volume":"30","author":"Li","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.003_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jth.12051","article-title":"Rho GTPases in platelet function","volume":"11","author":"Aslan","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.003_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jtha.2026.01.003_bib37","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jtha.2026.01.003_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jtha.2026.01.003_bib39","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3389\/fimmu.2018.02279","article-title":"Sex hormones in acquired immunity and autoimmune disease","volume":"9","author":"Moulton","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.01.003_bib40","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.3802\/jgo.2020.31.e11","article-title":"LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer","volume":"31","author":"Kunitomi","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jtha.2026.01.003_bib41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12885-019-5548-x","article-title":"Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis","volume":"19","author":"Takenami","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtha.2026.01.003_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/blood-2018-04-844480","article-title":"The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses","volume":"133","author":"Zhao","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-025-02188-x","article-title":"Transmembrane thiol isomerase TMX1 inhibits fibrin formation by down-regulation of platelet phosphatidylserine exposure","volume":"23","author":"Zhao","year":"2025","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jtha.2026.01.003_bib44","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1182\/blood.2020007389","article-title":"A zinc transporter, transmembrane protein 163, is critical for the biogenesis of platelet dense granules","volume":"137","author":"Yuan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.003_bib45","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2026.01.003_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2141.2003.04324.x","article-title":"The role of P-selectin in the immune destruction of platelets","volume":"121","author":"Turner","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.01.003_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/CS20140714","article-title":"PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis","volume":"129","author":"Park","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jtha.2026.01.003_bib48","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3390\/cells11182925","article-title":"Proteomics identifies substrates and a novel component in hSnd2-dependent ER protein targeting","volume":"11","author":"Tirincsi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jtha.2026.01.003_bib49","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1055\/s-0038-1668545","article-title":"Relapse rate in survivors of acute autoimmune thrombotic thrombocytopenic purpura treated with or without rituximab","volume":"118","author":"Falter","year":"2018","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:16:07Z","timestamp":1781939767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626000449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1538783626000449"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.003","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow proteomic profiling reveals TMEM109 as a biomarker for relapse in thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}